|
RPP14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62581059726108E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.88098491916389E-15 |
| Normal-vs-Stage2 |
2.26489999999302E-06 |
| Normal-vs-Stage3 |
5.70420000012284E-07 |
| Normal-vs-Stage4 |
1.7924994821783E-10 |
| Stage1-vs-Stage2 |
8.754200E-01 |
| Stage1-vs-Stage3 |
7.413600E-01 |
| Stage1-vs-Stage4 |
1.164220E-01 |
| Stage2-vs-Stage3 |
9.099600E-01 |
| Stage2-vs-Stage4 |
1.500770E-01 |
| Stage3-vs-Stage4 |
2.255000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62547753035369E-12 |
| Normal-vs-AfricanAmerican |
2.17093010235203E-12 |
| Normal-vs-Asian |
2.298200E-02 |
| Caucasian-vs-AfricanAmerican |
9.884400E-01 |
| Caucasian-vs-Asian |
5.916800E-01 |
| AfricanAmerican-vs-Asian |
5.737000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
6.65880017791665E-10 |
| Male-vs-Female |
5.135800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.03770042242979E-10 |
| Normal-vs-Extreme_Weight |
6.66133814775094E-15 |
| Normal-vs-Obese |
1.89048776633172E-12 |
| Normal-vs-Extreme_Obese |
7.897800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.941000E-01 |
| Normal_Weight-vs-Obese |
7.892600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.365800E-01 |
| Extreme_Weight-vs-Obese |
4.403000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.131600E-01 |
| Obese-vs-Extreme_Obese |
4.988800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.51499999714966E-08 |
| Normal-vs-Age(41-60Yrs) |
1.66500147003035E-12 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
9.83799999999535E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.129800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.954800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.921000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.067000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.228400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.830000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.32986979603811E-15 |
| Normal-VS-Type2 PRCC |
6.12077055706095E-12 |
| Normal-VS-KIRP CIMP |
1.81059999992961E-07 |
| Normal-VS-Unclassified PRCC |
4.53829995805677E-09 |
| Type1 PRCC-VS-Type2 PRCC |
4.099800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.027000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.335600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.932200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.551800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.404200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6251444634463E-12 |
| Normal-vs-N1 |
6.88639999468776E-08 |
| Normal-vs-N2 |
2.12440000035841E-07 |
| N0-vs-N1 |
4.349600E-01 |
| N0-vs-N2 |
4.845600E-01 |
| N1-vs-N2 |
3.247400E-01 |
|
|
